Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Quidel Cp (QDEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,261,663
  • Shares Outstanding, K 39,818
  • Annual Sales, $ 522,290 K
  • Annual Income, $ 74,180 K
  • 60-Month Beta 1.31
  • Price/Sales 4.26
  • Price/Cash Flow 12.20
  • Price/Book 4.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.36
  • Number of Estimates 3
  • High Estimate 0.46
  • Low Estimate 0.31
  • Prior Year 0.29
  • Growth Rate Est. (year over year) +24.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.05 +0.68%
on 05/23/19
67.92 -19.88%
on 05/06/19
-8.11 (-12.97%)
since 04/23/19
3-Month
54.05 +0.68%
on 05/23/19
69.50 -21.70%
on 03/15/19
-13.32 (-19.66%)
since 02/22/19
52-Week
44.27 +22.93%
on 12/24/18
77.63 -29.90%
on 08/31/18
-8.32 (-13.26%)
since 05/23/18

Most Recent Stories

More News
ABIOMED Gets FDA Confirmation of the Safety of Impella RP

ABIOMED (ABMD) receives the FDA confirmation of the safety and effectiveness of the company's Impella RP heart pump.

ABMD : 262.64 (-1.07%)
HAE : 99.05 (-3.34%)
CSII : 38.93 (-1.79%)
QDEL : 54.42 (-4.19%)
Masimo Gets FDA Nod for Radius PPG, Boosts Patient Monitoring

Masimo (MASI) receives FDA 510 (k) clearance for Radius PPG, which is set to become an important breakthrough in patient monitoring.

MASI : 137.72 (-2.03%)
HAE : 99.05 (-3.34%)
CSII : 38.93 (-1.79%)
QDEL : 54.42 (-4.19%)
Here's Why You Should Retain Cooper Companies (COO) Stock

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex volatility remains a concern.

COO : 291.93 (-0.55%)
HAE : 99.05 (-3.34%)
CSII : 38.93 (-1.79%)
QDEL : 54.42 (-4.19%)
Here's Why You Should Retain DaVita (DVA) in Your Portfolio

DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, divestment of DMG segment might lower cash flows.

HAE : 99.05 (-3.34%)
DVA : 48.15 (-2.23%)
QDEL : 54.42 (-4.19%)
CSII : 38.93 (-1.79%)
Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) is gaining steadily from its core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

HAE : 99.05 (-3.34%)
PKI : 86.13 (-0.20%)
CSII : 38.93 (-1.79%)
QDEL : 54.42 (-4.19%)
QDEL vs. GNNDY: Which Stock Is the Better Value Option?

QDEL vs. GNNDY: Which Stock Is the Better Value Option?

GNNDY : 144.8000 (-2.33%)
QDEL : 54.42 (-4.19%)
Quidel (QDEL) Misses Q1 Earnings and Revenue Estimates

Quidel (QDEL) delivered earnings and revenue surprises of -11.65% and -6.08%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

QDEL : 54.42 (-4.19%)
Quidel: 1Q Earnings Snapshot

SAN DIEGO (AP) _ Quidel Corp. (QDEL) on Wednesday reported first-quarter net income of $24.8 million.

QDEL : 54.42 (-4.19%)
Quidel Reports First Quarter 2019 Financial Results

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for...

QDEL : 54.42 (-4.19%)
Analysis: Positioning to Benefit within Quidel, Altra Industrial Motion, LTC Properties, and Equity Lifestyle Properties -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quidel Corporation (NASDAQ:QDEL),...

AIMC : 32.60 (-3.69%)
LTC : 45.74 (-0.09%)
ELS : 120.15 (+1.49%)
QDEL : 54.42 (-4.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade QDEL with:

Business Summary

Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout...

See More

Key Turning Points

2nd Resistance Point 58.09
1st Resistance Point 56.26
Last Price 54.42
1st Support Level 53.32
2nd Support Level 52.21

See More

52-Week High 77.63
Fibonacci 61.8% 64.89
Fibonacci 50% 60.95
Fibonacci 38.2% 57.01
Last Price 54.42
52-Week Low 44.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar